Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways January 2026

Market Pathways' editors highlight the major policy issues and developments they'll be tracking in 2026 and count down the 10 most significant global policy documents of 2025. Tamara Syrek Jensen, former head of CMS' Coverage and Analysis division speaks candidly about the challenges of the current reimbursement structure and how companies can better interact with regulators. CMS initiates competitive bidding for diabetes devices; and a look at the proposed overhaul of MDR and IVDR.

Read Article